Ostarine Cycle Length: How Long to Run MK-2866

Short answer: users typically run ostarine (MK-2866) for 8 weeks, sometimes up to 12. The trials ran longer and at much lower doses: 86 days (about 12 weeks) at 0.1–3 mg a day in older adults, up to 113 days in cancer patients, 147 days in the Phase 3 lung cancer trials, and 16 weeks with semaglutide (Dalton 2011, Dobs 2013, POWER 1, Veru 2025). Testosterone and HDL fell within those trials, so a longer cycle means longer exposure to those effects.

The most important thing

The original author’s point still stands: if the product isn’t what the label says, the cycle length hardly matters. In a JAMA test, only 52% of products sold as SARMs contained a SARM and 41% matched the label (Van Wagoner 2017). After that, dose matters more than length: all the measured side effects rose with dose. See ostarine dosage.

Ostarine cycle length

Users usually run 8 weeks, and extend to 12 if they “feel good”. Feeling good is not a measure of suppression: in the 86-day trial, total testosterone fell by about 6–7 nmol/L in older men at 1–3 mg, while free testosterone, LH and FSH did not change significantly (Dalton 2011). How quickly levels recover after higher user doses has not been studied. The old claim that 8–12 weeks never needs a PCT has been removed; bloodwork at the end of a cycle tells you where you stand (ostarine PCT).

Example cycles

Evidence level: anecdotal. The doses in this section are what users commonly report, kept from the original article. No trial tested them; they are several times the doses studied.

Two commonly reported single-compound cycles from the original article:

Cutting cycle

Users describe keeping muscle on a calorie deficit; the trial evidence for that is the semaglutide study at 3–6 mg a day.

Bulking cycle

Diet and training drive most of the result: the trial gain at 3 mg was 1.3 kg over 86 days.

Conclusion

Users run ostarine for about 8 weeks, sometimes 12; trials ran 12–21 weeks but at 1–3 mg a day. Longer cycles mean longer exposure to lower HDL and testosterone and to liver-enzyme rises, and nobody has studied the higher user doses over any length. Compare compounds in the SARMs database and see ostarine before and after for what 8-week cycles looked like.